Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech    DIM   FR0013154002

SARTORIUS STEDIM BIOTECH

(DIM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
01/18/2021 01/19/2021 01/20/2021 01/21/2021 01/22/2021 Date
309.8(c) 315(c) 318.4(c) 322.4(c) 329.8 Last
54 023 68 161 62 658 51 114 59 375 Volume
-0.06% +1.68% +1.08% +1.26% +2.30% Change
More quotes
Financials
Sales 2020 1 877 M 2 284 M 2 284 M
Net income 2020 342 M 416 M 416 M
Net Debt 2020 261 M 318 M 318 M
P/E ratio 2020 86,6x
Yield 2020 0,29%
Sales 2021 2 270 M 2 762 M 2 762 M
Net income 2021 417 M 507 M 507 M
Net Debt 2021 164 M 200 M 200 M
P/E ratio 2021 70,6x
Yield 2021 0,36%
Capitalization 29 719 M 36 093 M 36 151 M
EV / Sales 2020 16,0x
EV / Sales 2021 13,2x
Nbr of Employees 6 979
Free-Float 25,7%
More Financials
Company
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and... 
More about the company
Notations Surperformance© of Sartorius Stedim Biotech
Trading Rating : Investor Rating :
More Ratings
All news about SARTORIUS STEDIM BIOTECH
01/15SARTORIUS STEDIM BIOTECH : Partners With RoosterBio to Advance Cell and Gene...
PU
01/06SARTORIUS STEDIM BIOTECH : to acquire Novasep's chromatography...
PU
01/05SARTORIUS STEDIM BIOTECH : Annual Report 2020 of the Liquidity Contract with the..
PU
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 -3-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 -2-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Bilan SEMESTRIEL S2 du contrat de liquidité contra..
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -3-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of -2-
DJ
01/05SARTORIUS STEDIM BIOTECH SA : Full-year report of the liquidity contract with th..
DJ
01/04SARTORIUS STEDIM BIOTECH SA : Declaration relative au nombre d'actions et de dro..
DJ
01/04SARTORIUS STEDIM BIOTECH SA : Declaration relative to the number of shares and v..
DJ
2020SARTORIUS STEDIM BIOTECH : Monthly statement on outstanding equity shares and vo..
CO
2020SARTORIUS STEDIM BIOTECH : refinances syndicated loan and increases financing...
PU
2020SARTORIUS STEDIM BIOTECH : acquires filtration expert WaterSep...
PU
2020SARTORIUS STEDIM BIOTECH SA : Declaration relative au nombre d'actions et de dro..
DJ
More news
News in other languages on SARTORIUS STEDIM BIOTECH
01/06SARTORIUS : vers l'acquisition d'une division de Novasep
01/06SARTORIUS STEDIM BIOTECH : veut acquérir la division d'équipements de chromatogr..
01/06Sartorius übernimmt Chromatographie-Prozessanlagen von Novasep
01/06SARTORIUS STEDIM BIOTECH : projette d'acquérir la division des...
01/06EN DIRECT DES MARCHES : Alstom, Rubis, Pixium, Carmat, X-Fab, Amazon, Tiffany, A..
More news
Analyst Recommendations on SARTORIUS STEDIM BIOTECH
More recommendations
Stock Trading Strategies
SARTORIUS STEDIM BIOTECH - 01/20
No turn-around in sight
BUY
More Stock Trading Analysis
Chart SARTORIUS STEDIM BIOTECH
Duration : Period :
Sartorius Stedim Biotech Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS STEDIM BIOTECH
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Average target price 289,63 €
Last Close Price 322,40 €
Spread / Highest target 20,3%
Spread / Average Target -10,2%
Spread / Lowest Target -40,1%
EPS Revisions
Managers and Directors
NameTitle
Joachim Kreuzburg Chairman & Chief Executive Officer
Volker Niebel Executive VP-Operations & Information Technology
Oscar-Werner Reif Executive VP-Research & Development
Henri Riey Independent Non-Executive Director
Anne-Marie Graffin Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
SARTORIUS STEDIM BIOTECH10.71%36 093
ABBOTT LABORATORIES3.16%193 529
MEDTRONIC PLC0.66%158 709
BECTON, DICKINSON AND COMPANY4.67%76 174
HOYA CORPORATION-5.57%48 389
ALIGN TECHNOLOGY, INC.1.76%42 880